Population pharmacokinetic-pharmacodynamic (PKPD) modeling of ibrutinib in patients with B-cell malignancies. Poggesi, I., Sardu, M., Marostica, E., Sukbuntherng, J., Chang, B. Y., de Jong, J., de Trixhe, X., Vermeulen, A., De Nicolao, G., O'Brien, S., Byrd, J. C., Advani, R. H., James, D., Deraedt, W., Beaupre, D., Wang, M. AMER ASSOC CANCER RESEARCH. 2015

View details for DOI 10.1158/1557-3265.HEMMAL14-B19

View details for Web of Science ID 000361386200055